Search results

Filters
Close
ADDED DATE
Added date
AUTHOR Please select
TOPICS Please select
WATCH / LISTEN / READ TIME
EHRA 2019: Internal vs. External Electrical Cardioversion of Atrail Arrhythmias in Patients With an Implantable Cardioverter-Defibrillator (ICD)
Author(s): Jakob Luker Added: 5 years ago
Dr Jakob Lüker (University Hospital Cologne, DE) discusses internal vs. external electrical cardioversion of atrail arrhythmias in patients with an implantable cardioverter-defibrillator (ICD). Filmed on site by Radcliffe Cardiology. Questions: 1. What is the concern with atrial conversions in patients with AICDs (automated implantable cardioverter defibrillator)? (00:10) 2. How does… View more

Electrophysiology & Arrhythmia
Job title: Cardiologist
Dr Bruce Wilkoff is the Director of Cardiac Pacing and Tachyarrhythmia Devices and a staff cardiologist at Cleveland Clinic Main Campus, Cleveland, US. Dr Wilkoff is also a Professor of Medicine at Cleveland Clinic Lerner College of Medicine at Case Western Reserve University. He is board-certified in internal medicine, cardiovascular disease and a Certified Cardiac Device Specialist. His… View more
Research Area(s) / Expertise:
Sudden Cardiac Death in Ischaemic Cardiomyopathy
Author(s): Saad M Ezad , Girish Babu , Peter O’Kane Added: 1 year ago

Heart Failure

Electrophysiology & Arrhythmia
Job title: Professor
Prof Paul Kalra is Professor of Cardiologyat Portsmouth Hospitals NHS Trust, UK.The majority of his work involves assessment, investigation and management of patients with known or suspected cardiac problems. While he has a broad interest in all aspects of general adult cardiology, his sub-specialty interest is the assessment and management of patients with heart failure. Prof Kalra has… View more
Author(s): Christian Besler , Christopher U Meduri , Philipp Lurz Added: 3 years ago
Accumulating evidence suggests that tricuspid regurgitation (TR) is independently associated with reduced long-term survival in the community and patients with ischaemic or dilated cardiomyopathy.1 Patients with moderate-to-severe TR suffer symptoms of progressive right heart failure, which are often difficult to treat with diuretic therapy. Prevalence estimates based on data from the Framingham… View more

Vascular Disease and Surgery

Intervention
Author(s): Constantinos O’Mahony , Saidi Mohiddin , Charles Knight Added: 3 years ago
Hypertrophic cardiomyopathy (HCM) is a genetic disorder of cardiac muscle with a heterogeneous clinical course.1 The disease is clinically characterised by left ventricular hypertrophy (LVH), which is typically asymmetric, and a subgroup of patients have left ventricular outflow tract obstruction (LVOTO) caused by systolic anterior motion (SAM) of the mitral valve leaflet(s).2,3 LVOTO is often… View more

Heterogeneous Populations

Heart Failure
Author(s): Alfredo Galassi , Aaron Grantham , David Kandzari , et al Added: 3 years ago
Section A Coronary Chronic Total Occlusions – Prevalence and Pathophysiology A chronic total occlusion (CTO) is defined as a completely occluded coronary artery with no antegrade flow (thrombolysis in myocardial infarction [TIMI] 0 flow) for at least three months.1 CTOs are present in 15–30 % of patients undergoing coronary angiography.2–5 In a Canadian prospective registry of 14,439 patients… View more

Heart Failure

MI/ACS
Revascularisation for Ischaemic Cardiomyopathy
Author(s): Matthew E Li Kam Wa , Saba Z Assar , Ajay J Kirtane , et al Added: 8 months ago

Vascular Disease and Surgery

Heart Failure
JIMPosters
Author(s): Inderjeet Singh Monga Added: 2 years ago

Intervention